DUCT CARCINOMA INSITU - PREDICTORS OF LOCAL RECURRENCE AND PROGRESSION IN PATIENTS TREATED BY SURGERY ALONE

被引:75
作者
PRICE, P
SINNETT, HD
GUSTERSON, B
WALSH, G
AHERN, RP
MCKINNA, JA
机构
[1] INST CANC RES,SUTTON SM2 5PX,SURREY,ENGLAND
[2] ROYAL MARSDEN HOSP,BREAST UNIT,LONDON,ENGLAND
[3] ROYAL MARSDEN HOSP,DEPT COMP SCI,LONDON,ENGLAND
关键词
D O I
10.1038/bjc.1990.194
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Between 1972 and 1982, 60 patients with histologically proven duct carcinoma in situ (DCIS) without evidence of invasive disease were treated by surgery alone. Treatment was not randomised and was total mastectomy (19), subcutaneous mastectomy (6) or local excision (35). Follow-up was by clinical examination and mammography with a median follow-up of 9 years (range 4-16 years). Twenty-six patients (43%) have recurred locally. The estimated proportion recurrence free at 7 years is 59% (95% Cl 46-72%). Local recurrence on the chest wall occurred in one patient having total mastectomy and in the chest wall or nipple in three patients having subcutaneous mastectomy. Twenty-two patients recurred locally in the breast after conservative surgery. The 7-year recurrence-free rates were 94%, 44% and 45% respectively in the three groups. Of those patients who recurred locally 14/26 (54%) did so with invasive disease. Of the 34 who did not develop local recurrence, two developed metastases. The only factor which correlated with local recurrence and invasive local recurrence on multivariate analysis was conservative surgery (hazard ratio 4. 71 (1. 59-14. 0), P=0. 001, and 4. 05 (1. 00-18. 7), P=0. 03, respectively). DCIS can be an aggressive local disease and local excision may be inadequate treatment. © The MacMillan Press Ltd., 1990.
引用
收藏
页码:869 / 872
页数:4
相关论文
共 27 条
[1]  
ASHIKARI R, 1971, CANCER, V28, P1182, DOI 10.1002/1097-0142(1971)28:5<1182::AID-CNCR2820280515>3.0.CO
[2]  
2-H
[3]  
ASHIKARI R, 1977, CANCER, V39, P435, DOI 10.1002/1097-0142(197702)39:2<435::AID-CNCR2820390211>3.0.CO
[4]  
2-W
[5]  
BROWN PW, 1976, ARCH SURG-CHICAGO, V111, P1063
[6]  
CARPENTER R, 1987, BRIT J CANCER, V56, P859
[7]  
Farrow J H, 1970, Cancer, V25, P468, DOI 10.1002/1097-0142(197002)25:2<468::AID-CNCR2820250226>3.0.CO
[8]  
2-0
[9]  
FISHER ER, 1975, CANCER, V35, P247, DOI 10.1002/1097-0142(197501)35:1<247::AID-CNCR2820350130>3.0.CO
[10]  
2-S